🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

29 recruiting trials

for Appendiceal Cancer

An International Study on Pediatric Patients With Rare Tumors. NCT07072143n/a1 site📍 Padova Azienda Ospedaliera di Padova Ph II Intraperitoneal Paclitaxel + System Therapy in GI Ca w/Peritoneal Carcinomatosis (STOPGAP-B) NCT07795749Phase 21 site📍 Orange University of California, Irvine · Tests: Paclitaxel Q2W, Paclitaxcel Q3W Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC NCT04779554Phase 22 sites📍 Lexington📍 Burlington Prakash Pandalai · Tests: Mitomycin C, flat dose 40 mg, Mitomycin C, weight-based dose 12.5 mg/m2 Molecular Profiling for Risk Stratification in Appendiceal Cancer NCT07587268n/a1 site📍 Durate City of Hope Medical Center · Tests: DNA Methylation Profiling, m6A Epitranscriptomic Profiling Genetics of Appendix Cancer Study NCT05734430n/a1 site📍 Nashville Andreana Holowatyj, PhD, MSCI · Tests: Genetic profiling, Retrospective tissue procurement Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG) NCT06101277NA1 site📍 Sacramento University of California, Davis · Tests: Ablative local therapy Technical Feasibility of Modified Early Post-Operative Intraperitoneal Chemotherapy (mEPIC) NCT05913674Phase 21 site📍 Montreal Ciusss de L'Est de l'Île de Montréal · Tests: Modified early post-operative intraperitoneal chemotherapy (mEPIC) Metformin in Pseudomyxoma Peritonei Secondary to Appendiceal Mucinous Neoplasms NCT07693452Phase 21 site📍 Orange University of California, Irvine · Tests: Metformin Molecular Characterisation of Appendiceal Cancer NCT05364788n/a1 site📍 Manchester The Christie NHS Foundation Trust · Tests: Retrospective tissue sample analysis The Appendix Cancer PMP Research Foundation Natural History Study/Patient Registry NCT07769346n/a1 site📍 Springfield Appendix Cancer Pseudomyxoma Peritonei Research Foundation NALIRIFOX (Nal-IRI Plus 5-FU/LV Plus Oxaliplatin) as First-Line Treatment for Patients With Advanced Small Intestine and Appendiceal Cancers NCT07060014Phase 12 sites📍 Houston📍 Houston The Methodist Hospital Research Institute · Tests: Patients will be treated with NALIRIFOX (liposomal irinotecan 50 mg/m2 + 5-FU 2400 mg/m2 + LV 400 mg/m2 + oxaliplatin 6… PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer NCT04329494Phase 13 sites📍 Duarte📍 Jacksonville📍 Greenlawn City of Hope Medical Center · Tests: Biopsy, Cisplatin, Doxorubicin, Fluorouracil, Intraperitoneal Chemotherapy A Feasibility Study of Mass-Based Response Drug Screening to Guide Personalized Hyperthermic Intraperitoneal Chemotherapy for High-Grade Appendiceal and Colorectal Adenocarcinoma With Peritoneal Metastasis NCT07291180NA1 site📍 New Haven Yale University · Tests: Mass-based response testing (MRT) Target-specific immunoPET Imaging of Digestive System Carcinoma NCT06715839NA1 site📍 Shanghai RenJi Hospital · Tests: [68Ga]Ga-DOTA-H2D3, [18F]F-RESCA-RB14, [68Ga]Ga-NOTA-T4, [18F]F-RESCA-T4, [68Ga]Ga-NOTA-G5 EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer. NCT06263088NA1 site📍 Cleveland Case Comprehensive Cancer Center · Tests: EQUITY GI Individualized Dose Escalation of 5-FU for Gastrointestinal Cancer NCT05780684NA1 site📍 Lebanon Dartmouth-Hitchcock Medical Center · Tests: FOX dose-escalation algorithm A Prospective Feasibility Study Using ctDNA to Tailor Neoadjuvant Chemotherapy for Patients With Colorectal or Appendiceal Adenocarcinoma NCT05947838NA1 site📍 Houston M.D. Anderson Cancer Center · Tests: Circulating tumoral DNA directed neoadjuvant therapy arm Surufatinib and Sintilimab in Combination With Capecitabine for Metastatic Adenocarcinoma of Small Intestine or Appendix Carcinoma NCT05472948Phase 21 site📍 Guangzhou Sun Yat-sen University · Tests: Surufatinib, Sintilimab, Capecitabine Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors NCT06128551Phase 1, Phase 256 sites📍 Duarte📍 Orange📍 Sacramento Revolution Medicines, Inc. · Tests: Elironrasib, Daraxonrasib A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors NCT07020221Phase 1, Phase 220 sites📍 Los Angeles📍 Baltimore📍 Boston Verastem, Inc. · Tests: VS-7375, Cetuximab, Carboplatin + Pemetrexed + Pembrolizumab, Gemcitabine + Nab-paclitaxel, Pembrolizumab Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes NCT04907643NA1 site📍 Los Angeles Cedars-Sinai Medical Center · Tests: PICO G2 4k Safety and Efficacy of PIPAC Using Single Agent Mitomycin in Solid Tumors NCT07487168Phase 11 site📍 Tampa H. Lee Moffitt Cancer Center and Research Institute · Tests: Mitomycin C (MMC), Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer NCT05969860Phase 22 sites📍 Jacksonville📍 Grand Forks Mayo Clinic · Tests: Clinical Encounter, Home Health Encounter, Quality-of-Life Assessment, Questionnaire Administration TLR9 Immunotherapy for Peritoneal Carcinomatosis NCT07658196Phase 11 site📍 Providence Brown University · Tests: ACM-CpG Pressurized Intraperitoneal Aerosolized Chemotherapy With Mitomycin for the Treatment of Unresectable Appendix or Colorectal Cancer With Peritoneal Metastases, The IMPACT Trial NCT07271355Phase 35 sites📍 Goodyear📍 Duarte📍 Irvine City of Hope Medical Center · Tests: Bevacizumab, Biopsy Procedure, Biospecimen Collection, Computed Tomography, Fluorouracil Intraoperative Imaging of Gastrointestinal Malignancies Using Pafolacianine (CYTALUX™) NCT07124351Phase 41 site📍 Los Angeles Cedars-Sinai Medical Center · Tests: CYTALUX™ (pafolacianine) Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies NCT04847063Phase 11 site📍 Bethesda National Cancer Institute (NCI) · Tests: Sodium Thiosulfate, 5-Fluorouracil, Oxaliplatin, Doxorubicin, Hyperthermic Intraperitonial Chemotherapy A Phase I/II Study of Intraperitoneal Paclitaxel in Patients With Metastatic Appendiceal Adenocarcinoma NCT06207305Phase 1, Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Dexamethasone, Diphenhydramine, Famotidine, Paclitaxel Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays NCT07283939NA368 sites📍 Fairbanks📍 Phoenix📍 Fort Smith Alliance for Clinical Trials in Oncology · Tests: PAGODA algorithm, Oxaliplatin, Folinic Acid, Fluorouracil
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy